Abstract:Objective:To explore the clinical characteristics, genotypes and long-term outcomes of individuals with 3-methylglutaconic aciduria.Methods:The clinical features, biochemical data, genetic test results and treatment outcomes of six children with 3-methylglutaconic aciduria admitted to the Department of Endocrinology, Genetics and Metabolism, Xinhua Hospital from February 2017 to February 2019 were retrospectively analyzed and the Gesell developmental diagnosis schedule was performed to evaluate the development of four patients.Results:Among 6 children with 3-methylglutaconic aciduria 2 were males and 4 were females.Four cases had 3-methylglutaconic aciduria type Ⅰ and 2 cases had 3-methylglutaconic aciduria with deafness,encephalopathy, and Leigh-like syndrome. Five of 6 patients were detected by newborn screening among whom 4 remained asymptomatic, and only one had a postmortem diagnosis. Among them, 4 patients remained asymptomatic, while two presented with clinical symptoms such as jaundice and dyspnea and the age of disease onset was 1 and 2 days respectively. The concentration of 3-methylglutaconic acid in urine of all affected individuals was between 22.38 and 77.09 mmol/molCr, which was above the normal value. Genetic tests were performed for all patients. Eleven variants were identified in 2 genes, of which 10 variants were novel and only c.442C>T p.(R148X) has been previously reported; Seven variants (c.656-2delA, EX5-EX6 Del, c.942+3A>G, c.373C>T p.(R125W), c.895-3C>G, c.667C>T p.(R223X) and c.894+5G>A) were in AUH gene. The others (c.548G>A p.(R138Q), c.442C>T p.(R148X), c.1339C>T p.(R447X) and c.973dupA p.(M325Nfs*5) were in SERAC1 gene. After being treated with leucine diet restriction and L-carnitine, 4 patients with AUH gene variation who were from asymptomatic phase developed normally, whereas those 2 patients with SERAC1 gene variation had a poor prognosis. During the follow-up, 2 patients exhibited varying degrees of psychomotor retardation, the rest had normal course of development.Conclusions:There are significant clinical heterogeneities among individuals with 3-methylglutaconic aciduria. The most common pathogenic variants are splicing variations, followed by nonsense, missense and frameshift mutations. Leucine-free diet and oral L-carnitine therapy are effective for some patients. Newborn screening is essential for early diagnosis and improvement of prognosis.

[Clinical and Genetic Analysis of an Infant with 3-Methylglutaconic Aciduria Type VII].

[Clinical and Genetic Analyses of a Family with Atypical Nonketotic Hyperglycinemia Caused by Compound Heterozygous Mutations in the GLDC Gene].

[Clinical Features and Genetic Analysis of a Child with 3-Methylglutenedioic Aciduria Type VII Due to Novel Variants of CLPB Gene].

Analysis of MUT gene mutations in a patient with isolated methylmalonic acidemia]

[Genetic Analysis of Newborns with Abnormal Metabolism of 3-Hydroxyisovalerylcarnitine].

[CLPB Gene Mutations Analysis in a Case of Type 3-Methylglutaconic Aciduria].

Analysis of Six Children with 3-Methylglutaconic Aciduria

Clinical and Mutational Spectra of 23 Chinese Patients with Glutaric Aciduria Type 1.

Clinical and Molecular Investigation in Chinese Patients with Glutaric Aciduria Type I

Analysis of Clinical Features and the Results of Mass Spectrometry with Glutaric Acidemia Type I

Cinical treatment of 3-hydroxy-3-methylglutaric aciduria and a novel mutation on 3-hydroxy-3-methylglutaryl-coenzyme A lyase gene

[Clinical and Laboratory Studies on 28 Patients with Glutaric Aciduria Type 1].

Evaluation of the Clinical, Biochemical, Neurological, and Genetic Presentations of Glutaric Aciduria Type 1 in Patients from China

Clinical features and GCDH gene variants in three Chinese families with glutaric aciduria type 1: A case series and literature review

Clinical and genetic analysis of a case with atypical ethyl malonate encephalopathy

[Clinical characteristics and genetic analysis of a child with Galactosemia due to compound heterozygous variants of GALT gene]

Clinical and Genetic Analysis for Two Children with Congenital Disturbance of Glycosylation with PMM2 Gene Mutations

Biochemical and Molecular Features of Chinese Patients with Glutaric Acidemia Type 1 from Fujian Province, Southeastern China

Clinical and Molecular Genetic Analysis with Methylmalonic Acidemia Combined with Homocystinuria

Clinical and Molecular Genetic Characterization of Two Patients with Mutations in the Phosphoglucomutase 1 (PGM1) Gene

Mutation analysis of GCDH gene in eight patients with glutaric aciduria type I]